1. Fortunato, Fernanda, Farnè, Marianna, Ferlini, Alessandra. . The DMD gene and therapeutic approaches to restore dystrophin. In Neuromuscular disorders : NMD, 31, 1013-1020. doi:10.1016/j.nmd.2021.08.004. https://pubmed.ncbi.nlm.nih.gov/34736624/
2. Ling, Chao, Dai, Yi, Fang, Li, Wang, Kai, Zhang, Xue. 2019. Exonic rearrangements in DMD in Chinese Han individuals affected with Duchenne and Becker muscular dystrophies. In Human mutation, 41, 668-677. doi:10.1002/humu.23953. https://pubmed.ncbi.nlm.nih.gov/31705731/
3. Happi Mbakam, Cedric, Tremblay, Jacques P. 2023. Gene therapy for Duchenne muscular dystrophy: an update on the latest clinical developments. In Expert review of neurotherapeutics, 23, 905-920. doi:10.1080/14737175.2023.2249607. https://pubmed.ncbi.nlm.nih.gov/37602688/
4. Duan, Dongsheng. . Duchenne Muscular Dystrophy Gene Therapy in 2023: Status, Perspective, and Beyond. In Human gene therapy, 34, 345-349. doi:10.1089/hum.2023.29242.ddu. https://pubmed.ncbi.nlm.nih.gov/37219994/
5. Verhaart, Ingrid E C, Aartsma-Rus, Annemieke. . Therapeutic developments for Duchenne muscular dystrophy. In Nature reviews. Neurology, 15, 373-386. doi:10.1038/s41582-019-0203-3. https://pubmed.ncbi.nlm.nih.gov/31147635/
6. D'Ambrosio, Eleonora S, Mendell, Jerry R. 2023. Evolving Therapeutic Options for the Treatment of Duchenne Muscular Dystrophy. In Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 20, 1669-1681. doi:10.1007/s13311-023-01423-y. https://pubmed.ncbi.nlm.nih.gov/37673849/
智鼠故事 
